Drug profile

The FDA adverse-event record for Estradiol

113 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Estradiol. See the species affected, top reactions, and outcomes below.

113
adverse-event reports
15.9%
death-coded share
Cattle
most-reported species
14
Behavioural disorder NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
113
Total Reports
18
Deaths Reported
15.9%
Death Rate

Active Ingredients

Estradiol

Administration Routes

OtherUnknownTopicalSubcutaneousOral

Species Affected

Cattle 62
Dog 30
Unknown 12
Human 5
Cat 2
Other 1
Horse 1

Most Affected Breeds

Holstein-Friesian also known as Holstein 29
Unknown 18
Cattle (unknown) 15
Dog (unknown) 13
Crossbred Bovine/Cattle 8
Mixed (Cattle) 5
Pug 3
Poodle (unspecified) 2
Crossbred Canine/dog 2
Chihuahua 2

Most Reported Reactions

Behavioural disorder NOS 14
Death 12
Accidental exposure 11
Increased sexual interest 10
Mammary gland oedema 10
INEFFECTIVE, WEIGHT INC 8
Vaginal swelling 7
Lack of efficacy - NOS 7
Aggression 6
Alopecia NOS 5
Abnormal oestrus NOS 5
Mammary gland disorder NOS 5

Outcome Breakdown

Outcome Unknown
48 (54.5%)
Died
15 (17.0%)
Recovered/Normal
10 (11.4%)
Ongoing
10 (11.4%)
Euthanized
3 (3.4%)
Recovered with Sequela
2 (2.3%)

Estradiol Adverse Event Insights

113 reports name Estradiol; 18 recorded a death outcome (15.9% of reported events, not a population-level mortality rate). Active ingredient: Estradiol. Administration routes: Other, Unknown, Topical, Subcutaneous.

By species: Cattle (62 reports), Dog (30 reports), Unknown (12 reports). By breed: Holstein-Friesian also known as Holstein (29), Unknown (18), Cattle (unknown) (15).

Leading clinical signs: Behavioural disorder NOS (14), Death (12), Accidental exposure (11), Increased sexual interest (10). Outcome, 88 coded reports: Outcome Unknown leads at 54.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.